Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27031592 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Lucia Chico und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratori Aliveda S.r.l., 56042 Crespina Lorenzana, Italy. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Oxidative Stress, Neurodegenerative Diseases, Biological Products. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 191 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Neurodegenerative diseases (NDs) are among the leading causes of disability and mortality worldwide and are characterized by multifactorial pathogenesis involving interconnected mechanisms, such as oxidative stress, protein misfolding and aggregation, neuroinflammation, and mitochondrial dysfunction. Dysregulation of transcription factors, governing cellular defense responses, particularly nuclear factor erythroid 2–related factor 2 (Nrf2), a key regulator of antioxidant and proteostatic pathways, plays a critical role in neurodegenerative processes. Currently, available pharmacological treatments for NDs are largely symptomatic, as no disease-modifying therapies exist. Natural bioactive compounds have emerged as promising multi-target agents, demonstrating antioxidant, anti-aggregative, and anti-apoptotic properties, frequently mediated through activation of the Nrf2 signaling pathways. These compounds may represent valuable supportive strategies alongside conventional drug treatments, potentially contributing to the modulation of multiple pathogenic mechanisms. This review summarizes key oxidative stress- and protein aggregation-driven mechanisms underlying Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and Huntington’s disease. It further examines the neuroprotective potential of plant-, fungi-, and marine-derived natural compounds, with particular emphasis on Nrf2 activation. Beyond redox regulation, the broader role of Nrf2 in maintaining proteostasis is discussed. Overall, the review highlights Nrf2-inducing nutraceuticals as promising complementary, multi-target approaches for neuroprotection in NDs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratori Aliveda S.r.l., 56042 Crespina Lorenzana, Italy.
- Department of Clinical and Experimental Medicine, University of Pisa, 56100 Pisa, Italy.
ORCID-Profile: Lucia Chico, Gabriele Siciliano
Zitieren
APA
Chico, L., Schirinzi, E., Balestrini, L., Polzella, M., & Siciliano, G. (2026). Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27031592
Vancouver
Chico L, Schirinzi E, Balestrini L, Polzella M, Siciliano G. Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27031592
BibTeX
@article{Chico2026,
author = {Chico, Lucia and Schirinzi, Erika and Balestrini, Linda and Polzella, Maico and Siciliano, Gabriele},
title = {Nrf2-Activating Natural Compounds in Neurodegenerative Diseases: Targeting Oxidative Stress and Protein Aggregation},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27031592}
}
EUVIMED